documents: FDA-2007-D-0369-0069

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2007-D-0369-0069 FDA FDA-2007-D-0369 Draft Guidance for Industry; Availability: Bioequivalence Recommendations for Rifaximin Tablets Notice Notice of Availability 2012-02-13T05:00:00Z 2012 2 2012-02-13T05:00:00Z 2012-04-14T03:59:59Z 2012-02-13T16:12:13Z 2012-03234 0 0 0900006480fb4000

Links from other tables